RecallDepth
Class III Terminated

Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.

This recall has been terminated (originally issued April 7, 2021).

Company
Cardinal Health Inc.
Recall Initiated
March 9, 2021
Posted
April 7, 2021
Recall Number
D-0314-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
48 boxes
Firm Location
Dublin, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

Temperature Abuse

Distribution

AL, LA, MS, TN

Lot / Code Info

KESOY.AI Exp. 04/2022

More recalls by Cardinal Health Inc.

View all recalls by this company →

Other recent Class III Drug recalls